News
More information: Eleri A. Ashworth et al, Exploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivo, Nature Communications (2024).
13d
Clinical Trials Arena on MSNBiomX doses first subject in Phase IIb trial of cystic fibrosis treatmentBiomX has dosed the first subject in the randomised Phase IIb trial of the company’s fixed multi-phage therapy, BX004, to ...
Adaptive responses of Pseudomonas aeruginosa to treatment with antibiotics. Antimicrobial Agents and Chemotherapy, 2021; DOI: 10.1128/AAC.00878-21 ...
Pseudomonas aeruginosa is a type of bacteria commonly found in the environment, such as soil, water, and plants, and as part of bacteria residing in humans. It is both a pathogen and opportunistic ...
Pseudomonas aeruginosa is a master of survival. It thrives in soil and water—and in the human body, especially when the immune system is compromised. In hospitals, P. aeruginosa is one of the ...
Pseudomonas aeruginosa is a human pathogen which can cause life-threatening illness, especially in people who have a depleted immune system. One of the ways P. aeruginosa causes infection is ...
Pictured: an artist's impression of Pseudomonas aeruginosa bacteria, main, and plastic medical equipment, inset. ivan68 / quantic69/iStock / Getty Images Plus ...
Pseudomonas aeruginosa is an opportunistic pathogen responsible for morbidity and mortality in humans, animals, and plants. This bacterium has been regarded to be widely present in terrestrial and ...
They occur widely in nature. The type species Pseudomonas aeruginosa (Pseudomonas pyocyanea, Bacillus pyocyaneus) is pathogenic for man. It grows readily on all ordinary culture mediums.
Updated on: March 23, 2023 / 11:05 PM EDT / CBS News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results